1. Volume 139, Issue 5, Pages 1593-1601 (November 2010)
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin 
Mark G. Swain, Ming–Yang Lai, Mitchell L. Shiffman, W. Graham E. Cooksley, Stefan Zeuzem, Douglas T. Dieterich, Armand Abergel, Mário G. Pessôa, Amy Lin, Andreas Tietz, Edward V. Connell, Moisés Diago 
Gastroenterology 
Volume 139, Issue 5, Pages (November 2010)
DOI: /j.gastro
Copyright © 2010 AGA Institute Terms and Conditions

2. Figure 1
Randomized multicenter trials in which patients received peginterferon alfa-2a alone or in combination with ribavirin for the treatment of chronic hepatitis C. HVL, high viral load; RBV, ribavirin; tiw, three times weekly.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2010 AGA Institute Terms and Conditions

3. Figure 2
Patients negative for HCV RNA at last follow-up visit. SVR is defined as HCV RNA <50 IU/mL at the end of a 24-week follow-up phase.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2010 AGA Institute Terms and Conditions